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Summary 
CD40 is a 50-kD glycoprotein that plays an important role in B cell survival, memory, and 
immunoglobulin isotype switch. Engagement of the CD40 antigen by monodonal antibodies 
(mAbs) results in increased protein tyrosine kinase (FFK) activity, which plays an important 
role in mediating the biologic effects of CD40. We demonstrate, using an in situ phosphorylation 
technique, that CD40 cross-linking by the anti-CD40 mAb 626.1 resulted within 1 min in increased 
phosphorylation of the src type kinase, 1F:, in Dandi B cell lines and remained sustained for 
up to 20 rain. The activity of lyn kinase, as measured by immune complex kinase assay, was 
also increased after CD40 engagement, with similar kinetics. In contrast, the phosphorylation 
and activity offyn, fgr,  and kle kinases demonstrated minimal changes following stimulation 
of Dandi cells with mAb 626.1 over this same time period. CD40 engagement also resulted 
in phosphorylation of phospholipase C'y2 of phosphatidylinositol (PLC~/2) and phosphatidylinositol 
(PI)-3-kinase. Phosphorylation of PI-3-kinase was shown to be associated with an increase in 
its enzymatic activity. These results suggest that lyn plays an important role in CD40-mediated 
FFK activation and identify PI.C3'2 and PI-3-kinase targets for CD40-mediated phosphorylation, 
suggesting a role for these two enzymes in CD40 signal transduction. 
C 
D40 is a 50-kD transmembrane glycoprotein expressed 
on all mature B cells (1, 2). It plays a critical role in 
B cell survival, activation,  and differentiation.  Engagement 
of CD40 by mAb results in B cell proliferation (3, 4), homo- 
typic cell adhesion (5, 6), and expression of bd-2 protein in 
germinal center B ~  (7). In synergy with IL-4, mAbs against 
CD40 promote long-term B cell growth in culture (8) and 
induce resting B cells to undergo IgE isotype switching via 
ddetional switch recombination (9). A ligand for CD40 is 
expressed on T cells upon activation (10, 11). Interaction be- 
tween CD40 and its ligand appears to play an important role 
in T cell-dependent isotype switching because a soluble form 
of CD40 inhibits T cell-driven isotype switching to IgE in 
IL-4-treated B cells (12). Furthermore, Epstein-Barr virus- 
transformed B cells transfected with the CD40 ligand replace 
T cells in synergizing with IL-4 to induce IgE synthesis in 
B cells (11). 
B Hells stimulated by anti-CD40 mAb demonstrate increased 
protein tyrosine kinase (PTK)  1 activity,  1,4,5-inositol  tri- 
phosphate (IP3) production, and serine-threonine kinase ac- 
tivity (13). Activation of FTK appears to play an important 
role in mediating the biologic effects of CD40 because PTK 
inhibitors inhibit B cell aggregation (6) and isotype switching 
induced by anti-CD40 mAbs (14). The predicted amino acid 
sequence of the CD40 cytoplasmic region does not contain 
a kinase domain (15), suggesting that CD40-mediated PTK 
activity occurs indirectly, via activation of a separate kinase. 
However, the identity of that putative kinase has not yet been 
determined. 
We have investigated  the CD40 signal transduction pathway, 
focusing on the role of src-type FFK and subsequent  target 
substrates for CD40-mediated FTK activation. We now re- 
port that CD40 engagement results in the activation of the 
src-type FFK lyn and of phosphatidylinositol-3-kinase  (PI-3- 
kinase).  Furthermore, we show that both PI-3-kinase  and 
phospholipase C3'2 (PLC'y2) are substrates for CD40-mediated 
phosphorylation. Our findings suggest that these three pro- 
teins play an important role in CD40 signal transduction. 
1 Abbreviations used in this paper: IP3, 1,4,5-inositol triphosphate; NRS, 
normal rabbit serum; PDGFK, phtelet-derived growth factor receptor; 
Pl-3-kinase,  phosphatidylinositob3-kinase;  PI-3-P, phosphoinositol-3- 
phosphate; PLC, phospholipase C; FI"K, protein tyrosine kinase. 
Materials and Methods 
Cells, Antibodies, and Reagents.  The human B lymphoblastoid 
cell line, Daudi, was obtained from the American Type Culture 
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has previously been described (4). Goat anti-human IgM was ob- 
tained from Olympus Corp. (I~ke Success, NY), and the anti-LFA-1 
mAb, TS1/22, was obtained from ATCC. Rabbit anti-sera against 
PLC3'I and PI-3-kinase were obtained from Upstate Biotechnology, 
Inc. (Lake Placid, NY), while rabbit antiserum against PLC3,2 was 
a kind gift of  Dr. John Knopf (Genetics Institute, Cambridge, MA). 
Polyclonal antibodies directed against src-type FrK were generated 
in rabbits immunized  with synthetic peptides corresponding  to 
amino acid sequences 6-25 for lyn (16), 11-30 forfyn (17), 48-67 
forfgr (18), and 5-24 for kh (16); all these sequences correspond 
to the unique domain for each respective FFK. Phosphatidylino- 
sitol and rabbit muscle enolase were purchased from Sigma Chem- 
ical Co. (St. Louis, MO). 
In Situ Phosphorylation Assays.  Phosphorylation  of src-type ki- 
nases, PLC3~ isoenzymes, and PI-3-kinase was measured using an 
in situ phosphorylation  assay as previously described (19). Briefly, 
cells were depleted of intracellular  phosphate  by incubation  in 
phosphate-free MEM (GIBCO BRL, Gaithersburg,  MD) for 1 h 
at 370C. The cells were then  resuspended in the same medium 
at a density of 107 cdls/ml, stimulated  for 0-20 rain with anti- 
CD40 mAb, rapidly pelleted, and resuspended in 200 #1 of ice-cold 
permeabilization buffer containing  120 raM KCI, 30 mM NaC1, 
10 mM Hepes, pH 7.4, 10 mM MnCh, 2 mM MgCh,  100 nM 
CaC12, 100 mM Na3VnO4, and 28.5 mg/ml c~-lysophosphatidyl- 
choline (Sigma Chemical Co.). After incubation for 1 rain in per- 
meabilization buffer, ~/-[32p]ATP (100 mCi) was added to each 
sample, and the kinase reaction was allowed to occur for 15 min 
at 4~  At this temperature, FTK are active, while serine-threo- 
nine kinase activity ig greatly diminished (19). The kinase reaction 
was terminated by rapidly pelleting the cells and lysing with lysis 
buffer (1% NP-40, 150 mM NaC1, 20 mM Hepes, pH 7.4, 1 mM 
PMSF, 1 mM Na3VnO4, 50 mM NaF, 25 #g/ral leupeptin,  and 
1  #g/ml  each of chymostatin,  pepstatin,  and  antipain).  Im- 
munoprecipitates from the cell lysates were prepared by preclearing 
with normal rabbit serum and precipitating with specific antisera 
and protein G agarose as previously described (19). An aliquot of 
equal vohme from each immunoprecipitate was subjected to SDS- 
PAGE under reducing conditions. Radiohbeled proteins were visual- 
ized by autoradiography and densitometry was performed as previ- 
ously described (19). 
Immune  Complex Kinase Assays.  After  stimulation,  cells 
(107/ml) were lysed using  the same lysis buffer, and the lysates 
were precleared and specifically immunoprecipitated  as described 
above. The immunoprecipitates  were then resuspended in 50 #1 
kinase reaction  buffer  (0.5%  NP-40,  150 mM  NaC1, 10 mM 
MnC12, 10 mM MgClz, 20 mM Hepes, pH 7.4) with 5 #M ATP 
and 2.5 #Ci 3,-[32p]ATP. Acid denatured enolase (2.5 #g/sample) 
was added as an exogenous substrate. The reaction was terminated 
with Laemmli sample buffer, and equal volume aliquots from each 
sample were analyzed by SDS-PAGE. Phosphorylation  of enolase 
was then visualized by autoradiography  and quantitated  by den- 
sitometry. 
Western Blot Analysis.  To measure the amount ofpeptide in each 
sample, an aliquot of equal volume from each immunoprecipitate 
was transferred to polyvinylidene  difluoride membranes for Western 
blot analysis as previously described (20). Blots were incubated with 
rabbit  antiserum  of the appropriate  specificity followed by goat 
anti-rabbit  Ig conjugated to alkaline phosphatase, and then visual- 
ized using alkaline phosphatase developing  reagent (Bio-Rad Labora- 
tories, Hercules, CA). 
PI-3-Kinase Assays.  PI-3-kinase assays were carried out as de- 
scribed by Gold et al. (21). After stimulation,  cells (15  x  106/ml) 
were lysed and PI-3-kinase immunoprecipitates  were prepared as 
described above. The immunoprecipitates were then washed four 
times with 150 mM NaC1, 20 mM T_ris HC1 (pH 7.5). Kinase reac- 
tion buffer containing 0.2 mg/ml sonicated phosphatidylinositol, 
10 mM ATP, 200 mM adenosine, 20 mM MgCI2, and 20 mM 
Hepes, pH 7.4, and 10 #Ci 3,-[32P]ATP was added to each sample. 
The reaction was allowed to continue for 20 rain at room tempera- 
ture, and terminated by addition of 450/zl 1.0 M HC1. The lipid 
fraction was extracted with 225 #1 chloroform/methanol  (1:1) and 
concentrated  under nitrogen  to a volume of 50 #1. Each sample 
was spotted onto a silica gd TLC plate that had been impregnated 
with 1% potassium oxahte,  dried, and baked for 1 h at 1400C. 
The chromatograms  were then  developed in chloroform/meth- 
anol/water/NH~OH (18:14:3:1), dried, and exposed to x-ray film 
at  -800C. Formation of phosphatidylinositol-3-phosphate  (PI-3- 
P) was determined by comparing the stimulated samples to known 
standards run in parallel on the TIC plate. 
Results 
CD40 Engagement Results in Activation of lyn Kinase.  Li- 
gation of CD40 antigen on B cell lines by mAbs results in 
increased PTK activity as detected by tyrosine phosphoryla- 
tion of multiple proteins (13).  Because the cytoplasmic do- 
main of CD40 does not code for a kinase (15), we investigated 
the possibility that  a src type kinase plays a role in CD40- 
mediated PTK activation. 
The three major src type kinases expressed in B cells are 
lyn, fyn,  and blk (22). Due to differential mKNA splicing, 
two isoforms of lyn exist, with molecular masses of 53 and 
56 kD (23). Both isoforms are expressed in Daudi cells (24). 
Fyn also exists in two isoforms, with molecular masses 56 
and 59 kD, but only the 59-kD isoform is expressed in B 
cells (25).  Expression  of blk  by Daudi  cells  has  not  been 
reported. In addition to these three FTK, fgr expression has 
been reported in EBV transformed B cell lines, such as Daudi 
(26).  Expression  of kk in B cells and B cell lines has  also 
been reported  (27). 
We fast examined by an in situ phosphorylation technique 
the effect of CD40 engagement  on the phosphorylation of 
lyn. Fig. 1 A shows the results of a representative in situ phos- 
phorylation experiment.  Within  1 min after stimulation of 
Daudi calls with the anti-CD40 mAb 626.1, an increase  in 
phosphorylation of both lyn isoforms was noted. Phosphory- 
lation peaked at 5 rain and remained sustained for up to 20 
min. Western blot analysis of anti-CD40-stimulated  Dandi 
cell lysates showed equal amounts of precipitable kinase at 
all time points, indicating that the increase in lyn phosphory- 
lation noted after CD40 ligation was not merely due to a 
change in the amount of precipitated kinase (Fig.  1 B). Fig. 
1 C shows the pooled results from six different experiments. 
Phosphorylation of lyn kinase is expressed as relative phos- 
phorylation index.  This index is the ratio of the combined 
densitometric values of both lyn isoforms in stimulated versus 
unstimulated cells (time 0). The mean increase in lyn phos- 
phorylation was 3.8-fold at 1 rain,  5.38-fold at 5 min,  and 
dropped to <2-fold by 10 min poststimulation. 
In parallel with the in situ phosphorylation assays, we ex- 
amined the tyrosine kinase activity of lyn in Daudi ceUs stimu- 
674  CD40  Activates l~m Kinase Figure  1.  Effect  of CD40 engagement on phosphorylation of 17n ki- 
nase. (A) Daudi cells (107/ml) were stimulated with anti-CD40 mAb 
626.1 for the time periods (min) indicated. Phosphorylation of 17n was 
measured using the in situ phosphorylation assay  as described  in Materials 
and Methods. The migration positions of the 53- and 55-kD isoforms 
of Ilm are indicated  by the labeled  arrow. (B) Western blot of  aliquots from 
each immunoprecipitate sample, using lyn antiserum as a probe and alka- 
line phosphatase as the developing reagent as described in Materials and 
Methods. (C) Pooled results of six separate experiments. The mean rela- 
tive phosphorylation index at each time point was determined. Error bars 
represent  2 standard  errors.  The lanes labeled  NRS represent  immunoprecipi- 
tares prepared with control preimmune normal rabbit serum. 
latad with anti-CD40 mAbs using an immune complex ki- 
nase assay with enolase as a  substrate.  Fig.  2 A  shows the 
results  of a  representative immune  complex kinase experi- 
ment. Within 1 rain after stimulation with anti-CD40 mAb, 
l~m immunoprecipitates showed an increased capacity to phos- 
phorylata the substrata enolase. Lyn enzymatic activity peaked 
between  1 and 5  rain,  and remained elevated for up  to 20 
min. Western blot analysis confirmed that equivalent amounts 
of l),n were present in each lane (data not shown). Upon longer 
exposure of autoradiographs  generated from immune corn- 
Figure 2.  Effect  of  CD40 engagement  on 17n kinase  activity.  (A) Dandi 
cells (107/ml) were stimulated with mAb 626.1 for the time points indi- 
cated (min). Phosphorylation of enolase was detected using the immune 
complex kinase assay. The migration position of enolase is indicated by 
the labeled arrow. The lane labeled TS1/22 represents a sample of Daudi 
cells stimulated for 5 rain with the anti-LFA-1 mAb TS1/22. The lane 
labeled NKS represents  immunopreeipitates  prepared  with control preim- 
mune normal rabbit serum. (B) Prolonged exposure of an autoradiogram 
of another immune compl~ kinase assay performed under identical con- 
ditions as described above. Autophosphorylation of 17n can be seen. (C) 
Pooled results of six separate experiments. The mean relative  phosphory- 
lation inde~ of enolase  at each time point was determined. Error bars rep- 
resent 2 standard errors. 
plex kinase assays,  CD40-mediated lyn autophosphorylation 
was also observed, the intensity of which paralleled the en- 
zymatic activity of lyn upon the enolase substrate (Fig. 2 B). 
The results from six different experiments were pooled and 
shown in Fig. 2 C. Activity of lyn kinase is expressed as rela- 
tive enolase phosphorylation index.  This index is the ratio 
of the densitometric value of enolase in stimulated  vs.  un- 
stimulated cells (time 0). The mean increase in enolase phos- 
phorylation was  2.8-fold at  1 rain,  3.7-fold at  5  rain,  and 
remained  elevated 2.2-fold 20 rain poststimulation. 
The effect of anti-CD40 mAbs on lyn was specific, because 
stimulation  of Dandi  cells with  an isotype-matched mAb 
against LFA-1 (mAb TS1/22) had no effect on lyn kinase ac- 
tivity (Pig. 2 A). CD40-mediated activation of lyn kinase did 
not require engagement of ~  receptors on Daudi ceils, since 
biotinylated Fab fragments of mAb 626.1 cross-linked with 
675  ~  et al. avidin dicited equivalent degrees of lyn phosphorylation and 
enzymatic  activity as intact  antibody (data not  shown). 
In contrast to the effect of CD40 engagement on lyn, treat- 
malt of  Daudi ceils with anti-CD40 mAb resulted in markedly 
different effects on other src-type PTK. Minimal phosphory- 
lation offyn was observed in mAb 626.1-stimttlated Daudi 
cells  (Fig.  3 A).  In  three experiments,  maximal fyn phos- 
phorylation was 1.7-fold at 5 min poststimulation. There was 
also no significant increase infyn autophosphorylation or ki- 
nase activity towards the enolase substrate after CD40 en- 
gagement (Fig.  3 B). In four experiments,  maximalfyn ki- 
nase activity was 1.3-fold at 1 rain poststimulation.  Western 
blot analysis showed no change in predpitablefyn after stim- 
ulation with anti-CD40 mAb (Fig. 3 C). Fig. 4 shows that 
CD40 engagement resulted in a minimal, transient  phosphory- 
lation offgr at 1 rain (Fig. 4 A) and in no detectable change 
in kk phosphorylation  (Fig. 4 B). fgr and kk enzymatic ac- 
tivity were barely detectable using our immune complex ki- 
nase assay; no significant change was seen after stimulation 
of Dandi with anti-CD40 mAbs, although in the same ex- 
periment CD40-mediated lyn activation was dearly evident 
(data not shown). Western blots confirmed that equal amounts 
of kinase  were detected in each lane  (Fig.  4, B  and D). 
These results suggest a differential role for B call src type 
kinases in  CD40  signal  transduction. 
CD40 Engagement  Results in Phosphorylation  and Activation 
of  PI-3-Kinase  Engagement of cell surface receptors that de- 
Figure 3.  Effect  of CD40 engagement on phosphoryhtion  and activity 
offyn kinase. Daudi cells (107/ml) were stimulated with mAb 626.1 for 
the time periods  indicated (rain) and subjected  to (A) in situ phosphoryla- 
tion analysis  and (B) immune complex  kinase assay  performed onf~ im- 
munoprecipitates. (C') Western  blot of  aliquots from each immunoprecip- 
itate sample, using  fyn antiserum as a probe and alkaline phosphatase as 
the developing  reagent as described  in Materials and Methods. The migra- 
tion positions off~ and enolase are indicated by labeled arrows. 
Figure 4.  Effect  of  CD40 engagement on phosphoryhtion and activity 
offgr and kk. Daudi cells (107/ral) were stimulated with mAb 626.1 for 
the time periods  indicated (min) and in situ phosphorylation  analysis  was 
performed onfffand kk immunoprecipitates  as indicated. (A) in situ phos- 
phorylation assay using  fgr immunoprecipitates. (B) Western blot of ali- 
quots from each  immunoprecipitate  sample, usingfgr  antiserum as a probe 
and alkaline  phosphatase  as the developing  reagent as described  in Materials 
and Methods. (C) In situ phosphorylation  assay  using kk immunoprecipi- 
tates. (D) Western blot of aliquots from each immunoprecipitate sample, 
using kk antiserum as a probe and alkaline phosphatase as the developing 
reagent as described  in Materials and Methods. The migration positions 
of~r and kk are indicated by the labeled arrows. 
liver mitogenic signals, such as phtelet-derived growth factor 
receptor (PDGFR) (28), slg (21), and IL-2R (29), is associated 
with activation of the enzyme, PI-3-kinase, which catalyzes 
the phosphorylation  of phosphoinositols  on the 3' moiety 
(30).  PI-3-kinase appears to play a key role in mitogenesis, 
because abrogation of PI-3-kinase activation via PDGF receptor 
results in loss of PDGFR-induced mitogenesis  (28).  PI-3- 
kinase  is  a  heterodimer  consisting  of a  85-kD  regulatory 
subunit (p85) and a 110-kD catalytic subunit (p110) (30). Tyro- 
sine phosphorylation of the p85 chain is thought  to be im- 
portant  in  the regulation  of enzyme activity (21,  30,  31). 
Stimulation orB cells with anti-CD40 mAb 626.1 or with 
cells transfected with CD40 ligand results in their prolifera- 
tion (4,  11). To examine the capacity of CD40 engagement 
to phosphoryhte PI-3-kinase, Daudi ceils were stimulated with 
mAb 626.1 and phosphorylation of PI-3-kinase was assessed 
by the in situ phosphorylation technique, using a rabbit an- 
tibody directed against the p85 subunit. Fig. 5 A  shows that 
p85 phosphorylation peaked by 1 min after CD40 ligation 
and returned  to baseline by 10 min.  Western blot  analysis 
of the  cell  lysates  showed  no  change  in  the  amount  of 
precipitable  PI-3-kinase  after anti-CD40  stimulation,  indi- 
cating  that  increased p85 phosphorylation  was not due to 
an increased amount of protein (Fig. 5 B). Similar results were 
obtained in two other experiments.  CD40 engagement had 
a minimal effect on the phosphorylation of the p110 subunit 
of PI-3-kinase, which coprecipitates with p85 (32). A 90-kD 
phosphoprotein  was also seen in the PI-3-kinase immuno- 
precipitates and displayed minimal changes in phosphoryla- 
tion  after CD40 engagement. 
CD40-mediated phosphorylation of the p85 subunit of PI- 
3-kinase was accompanied by increased enzymatic activity. 
676  CD40  Activates lyn Kinase Figure  5.  Effect  of CD40 engagement on phosphorylation  of Pl-3- 
kinase. Daudi cells (107/ml) were stimulated  with mAb 626.1 for the 
times (rain) indicated. (A) Phosphorylation  of PI-3-kinase was measured 
using the in situ  phosphoryhtion  assay.  (B) Western  blot of aliquots from 
each of the immunoprecipitates  using anti-Pl-3-kinase  antiserum  and de- 
veloped  using  alkaline  phosphatase  system.  The position  of  the p85 subunit 
of PI-3-kinase is indicated  by the labeled arrow. 
Figure  6.  Effect  of CD40 engagement  on PI-3-kinase  activity.  Daudi 
cells (15 x 10S/ml)  were incubated  in for 5 min with mAb 626.1 or with 
goat anti-IgM  for 2 rain, as indicated.  PI-3-kinase  assays  were performed 
as described  in Materials  and Methods,  and PI-3-P  formation  was detected 
by TIC. The migration  position  of  PI-3-P is indicated  by the hbeled  arrow. 
The origin (labeled with arrow) contains residual 7-[3zP]ATP that was 
present in the lipid  extracts,  the absolute  amount  of  which  is not relevant. 
Hg.  6  shows  the  enzymatic  activity of PI-3-kinase  im- 
munoprccipitates isolated from Dandi cells stimulated for 5 
min with anti-CD40 mAb 626.1. PI-3-kinase immunopredpi- 
tates from unstimulated ceils and from cells stimulated with 
goat anti-human IgM were used as negative and positive con- 
trols, respectively. The results show that CD40 engagement 
resulted in a significant increase in PI-3-kinase activity, as evi- 
dence by increased  PI-3-P formation. 
Taken together, these resuhs identify  PI-3-kinase as a target 
for CD40-mediated phosphorylation and activation. 
CD40 Engagement  Results in Phosphorylation  of  PLC72.  The 
enzyme PLC hydrolyzes 4,5-inositol bisphosphate to form 
IP3 and diacylglycerol (33).  The results of prior investiga- 
tions suggest that the activity of PLC3' isoforms is regulated 
by  tyrosine  phosphorylation.  Epidermal  growth  factor- 
mediated tyrosine phosphorylation of PLC34 results in in- 
creased  catalytic activity of the enzyme (34).  Conversely, 
mutations in PLC3q that result in loss of tyrosine phosphory- 
lation sites prevent PDGF-mediated activation of the enzyme 
(35).  More importantly, ligation of antigen receptors  on T 
and B ceils results in tyrosine phosphorylation of PLC~/and 
in IP3 generation, and both events  are abrogated by treat- 
ment with PTK inhibitors (36-38). 
Stimulation of B ceil lines with anti-CD40 mAbs results 
in the generation of IP3 (13). This is inhibited by tyrosine 
kinase inhibitors, suggesting that PI.C~/may be a substrate 
for CD40-triggered FTK activity in B cells. Human B ceils 
express  two isoforms of PLC% PLC'yl, and PLC3,2.  The 
PLC3~2 isoform is expressed in much greater abundance than 
the PLC~/1 isoform in B cells, including Dandi ceils (39). 
Phosphorylation of PLC3~ was measured by in situ phosphory- 
lation. Fig. 7 A  shows that CD40 ligation on Dandi ceUs 
caused increased  phosphorylation of PLC3~2 which peaked 
by 1 min after stimulation and returned to basdine by 20 
min. Western blot analysis (Fig. 7 B) demonstrated that equiva- 
lent amounts of PLC~/2 were present in each sample.  Only 
minimal amounts of PLC'yl were detected in Daudi ceU ly- 
Figure 7.  ~ect of CD40 engagement  on PI.C72. Daudi  cells (107/ml) 
were stimulated  with mAb 626.1 for the times  (min) indicated.  (A) Phos- 
phorylation  of PI.C'y2  was measured  by in situ phosphorylation  analysis. 
(B) Western  blot of  aliquots  from  each  immunoprecipitate  using  anti-PI.C'y2 
antiserum  as a probe and de~'doped  with alkaline  phosphatase  system.  Po- 
sition of PLC3r2 is indicated  by the labeled arrows. 
677  Pen et al. sates by Western blot, as previously reported, and no changes 
in its phosphorylation could be detected after CD40 ligation 
(data  not shown). 
Discussion 
In this report we demonstrate that CD40 ligation results 
in the phosphorylation and activation of the src-type FTK 
lyn in B cells. We show that both PI-3-kinase  and PLC3'2 
are target substrates for CD40-mediated phosphorylation. PI- 
3-kinase phosphorylation was accompanied by activation of 
its enzymatic activity. PLC3,2 phosphorylation is consistent 
with the previously observed CD40-mediated generation of 
IP3. 
We demonstrated increased phosphorylation of lyn within 
1 min of CD40 engagement. The regulation of src-type ki- 
nases by tyrosine phosphorylation is complex. Dephosphor- 
ylation of a COOH-terminal phosphotyrosine results in in- 
creased enzymatic activity, leading to a net increase in tyrosine 
phosphorylation via autophosphoryhtion  (26). Under the con- 
ditions of our in situ phosphorylation assay, we could not 
assess the possibility that lyn undergoes a transient, early de- 
phosphorylation event. However, our studies of lyn activity 
in immune complex kinase assays provide direct evidence for 
CD40-mediated lyn activation. 
While our results present dear evidence for the involve- 
ment of lyn in CD40 signal transduction, we cannot rule 
out the possibility that other FIXs are also involved and con- 
tribute to CD40-mediated FTK activity. We observed min- 
imal changes in the phosphorylation and activity offjm and 
fgr, but no detectable change in/ok, after stimulation of Daudi 
cells with anti-CD40 mAbs for 1-20 rain, suggesting that 
these kinases do not participate in CD40-mediated FIX ac- 
tivity over this time interval. Further studies are required to 
ascertain the functional roles of lyn, fyn, and fgr in CD40 
signal transduction. We could not rule out activation of the 
B cell-specific FI~ blk, because the human blk sequence is 
not known and antiserum to human bile was not available. 
It remains to be established whether CD40 engagement could 
also activate cytoplasmic PTK, such as syk (40, 41) and the 
recently described B ceU-specific FFK, atk/bpk.  (42,  43). 
In several systems, src-type kinases which are activated by 
cell surface receptors have been found to associate physicaUy 
with the receptor complex. Examples include the association 
of IFa,fyn, and blk (25) with sIg, offyn with the TCR (44), 
and of kk with CD4 and CD8 (45). We have been unable 
to date to coprecipitate lyn with CD40 from cell lysates pre- 
pared with a limited panel of detergent buffers  (data  not 
shown). This does not preclude a physical association between 
lyn and CD40. Such an association may be tenuous and easily 
disrupted, even in the presence of mild detergents. Alterna- 
tively, lyn may transiently associate with CD40 only upon 
engagement of the receptor. 
In the case of several cell receptors on immune cells, in- 
duding the TCR, slg, FceRI, and FeyRIII (CD16), src-type 
kinases bind to receptor-associated  molecules that belong to 
a protein family including CD3 3,,/$,~', rob-l, B29, FceRI/~, 
and FceRI3, (46). The cytoplasmic domains of these chains 
share a common tyrosine-containing motif (D/E-XT-D/E- 
X2-Y-X3-L-X7-Y-X2-L/I) which is thought to be important 
in establishing a physical association between the SH2 do- 
mains of src-type kinases and these proteins (46). For CD4, 
a cysteine-rich cytoplasmic domain has been shown to be crit- 
ical for the binding of this receptor to p56kk (47). The cloned 
CD40 cDNA codes for neither of these two motifs, suggesting 
that association of lyn with CD40 may require different in- 
teractions between these two proteins. 
We identified PI-3-kinase as a target for phosphorylation 
after CD40 engagement in Daudi cells. More importantly, 
the enzymatic activity of PI-3-kinase was increased after CD40 
ligation. Given the importance of PI-3-kinase in mitogenesis 
and cell proliferation, activation of this enzyme may play a 
critical role in B cell proliferation in response to anti-CD40 
mAbs and to the CD40 ligand expressed on activated T cells. 
Another target of CD40-mediated phosphorylation was 
PLC3,2, the predominant PLC3' isoform in human B cells. 
We could not rule out PLC3,1 phosphorylation after anti- 
CD40 stimulation because of the low level of PLC3,1 expres- 
sion in Daudi ceils. Tyrosine phosphorylation of PLC'y by 
antigen receptor ligation has been reported to be associated 
with activation of this enzyme (36, 38). We did not directly 
measure PLC3,2 activity after anti-CD40 stimulation. How- 
ever, it is likely that PLC3,2 is responsible for CD40-mediated 
generation of IP3 which is blocked by PTK inhlbitors. 
Although activation of lyn,  PI-3-kinase,  and PLC3' are 
common features of signal transduction via sIg and CD40, 
engagement of these two receptors results in distinctly different 
biologic responses. While cross-linking of fig on immature 
B cells results in the induction of apoptosis, CD40 ligation 
prevents cell death (7, 48), and engagement of CD40, but 
not of sIg, synergizes with cytokines to induce isotype switch 
recombination (9). These differences in biologic activity sug- 
gest differences in components of the signal  transduction 
pathways  employed by these two B cell specific receptors. 
There is evidence to suggest that CD40-mediated FFK ac- 
tivation is functionally relevant. The PTK inhibitor genistein 
inhibits CD40-mediated B cell adhesion (49)  and CD40- 
mediated IgE synthesis in B cells pretreated with IL-4 to ex- 
press optimal levels of e germ line transcript (14). Engage- 
ment of the transmembrane protein tyrosine phosphatase 
CD45  has  been shown to inhibit CD40-mediated B  cell 
proliferation (4). Furthermore, in preliminary experiments, 
cross-linking of CD45 to CD40 inhibited IgE synthesis by 
IL-4-treated B ceUs, with negligible effect on the induction 
of e germ line transcripts (I.oh, R., C. L. Pen, and R. S. 
Geha, manuscript in preparation). These observations sug- 
gest that activation of FFK plays an important role in CD40- 
mediated biologic responses. 
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